Houston's ready for the artificial intelligence revolution. Yuichiro Chino/Getty Images

How ready is Houston for the rise of artificial intelligence? More ready than you might think.

In the recently released Global Cities' AI Readiness Index, Houston ranks ninth in the world among large cities (those with 5 million to million residents). Singapore topped the large-city list; Dallas appeared at No. 8.

"The age of technology is here, and we cannot afford to sit idle," Houston Mayor Sylvester Turner says in a recent release. "We must leap, not stroll, into the future."

The Oliver Wyman Forum, part of management consulting firm Oliver Wyman, based its AI ranking on surveys of residents and leaders in 105 global cities, along with a review of publicly available socioeconomic data. The group says its goal in compiling the ranking was to "start a data-informed conversation about how to address the very real opportunities and challenges of AI disruption."

"Houston has been working diligently over the past several years to grow a robust digital tech ecosystem," says Susan Davenport, senior vice president of economic development at the Greater Houston Partnership. "Previously, most surveys ranked Houston in the 30s in this area. When we see ourselves ranked ninth among large global cities and U.S. metros in AI readiness, it's a positive signal of our trajectory."

Signs of Houston's trajectory in the AI universe abound:

"When you think about Houston's core industries like energy, life sciences, and manufacturing, these are all data-intensive businesses that are ripe for disruption by AI and other digital technologies," Davenport says. "There is significant activity with AI already happening in the market, but I think we're still early on the growth curve, with a great deal of upside potential."

A recent search of job website LinkedIn found more than 200 AI-focused jobs available in the Houston area at employers like Shell, Accenture, Deloitte, Capgemini, HP, and EY.

Over the past year, the Greater Houston Partnership has led several trips to Silicon Valley to meet with companies involved in AI, cloud computing, and other technologies that enable businesses to harness the power of data.

"We are finding these innovative companies are very interested in tapping into the customer base here in Houston," Davenport says, "and we expect to see growth in this sector to continue over the next few years."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”